CoChat

YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma

Open access

Published version of a preprint

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Activation of YAP, a Hippo pathway effector, is an important resistance mechanism to BRAF inhibitor (BRAFi) in melanoma. Emerging evidence also suggests that YAP is involved in suppression of the antitumor immune response. However, the potential direct impact of YAP activity on cytotoxic T-cell immune responses has not been explored yet. Here, we show that BRAFi-resistant melanoma cells evade CD8+ T-cell immune responses in a PD-L1–dependent manner by activating YAP, which synchronously supports melanoma cell survival upon BRAF inhibition. PD-L1 expression is elevated in BRAFi-resistant melanoma cells, in which YAP is robustly activated, and YAP knockdown decreases PD-L1 expression. In addition, constitutively active YAP (YAP-5SA) increases PD-L1 expression by binding to an upstream enhancer of the PD-L1 gene and potentiating its transcription. Both BRAFi-resistant and YAP-5SA–expressing melanoma cells suppress the cytotoxic function and cytokine production of Melan-A–specific CD8+ T cells, whereas anti–PD-1 antibody reverses the YAP-mediated T-cell suppression. Moreover, nuclear enrichment of YAP in clinical melanoma samples correlates with increased PD-L1 expression. Our findings show that YAP directly mediates evasion of cytotoxic T-cell immune responses in BRAFi-resistant melanoma cells by upregulating PD-L1, and targeting of YAP-mediated immune evasion may improve prognosis of melanoma patients. Cancer Immunol Res; 6(3); 255–66. ©2018 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/2326-6066.cir-17-0320

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 51 references

Cited by

See all 260

Metadata

Authors
Kim, M. H., Kim, C. G., Kim, S.-K., Shin, S. J., Choe, E. A., Park, S.-H., Shin, E.-C., & Kim, J.
Affiliations
  • Korea Advanced Institute of Science and Technology (KR)
  • Yonsei University (KR)
Corresponding author
  • Park, Su-Hyung
  • Shin, Eui-Cheol
  • Kim, Joon
Venue
Cancer Immunology Research
Published
2018-02-28
Volume
6
Issue
3
Pages
255-266
ISSN
  • 2326-6066 (ISSN-L)
  • 2326-6074
OpenAlex
W2786027394
Cited by
241
References
51
Citations by year
2026: 23 · 2025: 29 · 2024: 25 · 2023: 32 · 2022: 44 · 2021: 28 · 2020: 29 · 2019: 24 · 2018: 7
FWCI
8.34
Type
journal article
Language
en
Licence
cc-by-nc-nd
Locations
  • Cancer Immunology Research (publishedVersion)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
  • National Research Foundation of Korea (2014R1A2A1A10053662 and 2016M3A9B4915821)
  • Ministry of Health and Welfare (HI15C2817)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
Keywords
YAP, PD-L1, BRAF inhibitor resistance, melanoma, immune evasion, CD8+ T cells, Hippo signaling pathway, transcriptional regulation, anti-PD-1 therapy, melanoma prognosis
MeSH terms
YAP-Signaling Proteins, Cell Survival, Humans, Melanoma, Phosphoproteins, Transcription Factors, CD8-Positive T-Lymphocytes, Drug Resistance, Neoplasm, Tumor Escape, Cell Line, Tumor, Protein Kinase Inhibitors, Proto-Oncogene Proteins B-raf, Adaptor Proteins, Signal Transducing, Immune Evasion, B7-H1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma. https://app.cochat.ai/papers/10.1158/2326-6066.cir-17-0320
The paper
Kim, M. H., Kim, C. G., Kim, S.-K., Shin, S. J., Choe, E. A., Park, S.-H., Shin, E.-C., & Kim, J. (2018). YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-17-0320

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.